Skip to main content
NVDA+0.37%AAPL+0.09%GOOGL-0.61%MSFT+0.25%AMZN+0.13%TSM+0.96%SPCX+5.15%META+0.17%AVGO+0.07%TSLA+0.09%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.43%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%ORCL+2.00%BAC-2.72%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%3988.HK+0.34%GE+1.91%1816.HK-0.69%MS-1.83%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.72%NZDUSD-1.71%EURUSD-1.17%AUDUSD-1.14%USDCHF+1.12%GBPUSD-1.04%USDTHB+0.98%CADJPY+0.89%NZDCAD-0.87%USDCAD+0.85%CHFJPY+0.72%GBPNZD+0.67%GBPJPY+0.65%NZDCHF-0.60%AUDJPY+0.57%EURNZD+0.55%AUDNZD+0.55%EURJPY+0.52%GBPTRY+0.41%EURCAD-0.36%GBPHKD+0.32%USDTRY+0.30%AUDCAD-0.30%GBPMXN-0.28%CADCHF+0.27%GBPCAD-0.20%USDILS+0.16%GBPAUD+0.11%EURGBP-0.08%USDCNH+0.06%GBPCHF+0.04%USDCOP-0.04%EURCHF-0.03%AUDCHF-0.03%USDHKD+0.02%NZDJPY+0.02%EURAUD0.00%SGDJPY0.00%CHFSGD0.00%NOKJPY0.00%EURCZK0.00%NZDSGD0.00%EURNOK0.00%NZDMXN0.00%PLNJPY0.00%USDMXN0.00%USDNOK0.00%EURPLN0.00%USDZAR0.00%CHFNOK0.00%USDPLN0.00%USDDKK0.00%USDSEK0.00%EURSEK0.00%GBPZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%GBPSGD0.00%USDSGD0.00%AUDSGD0.00%EURDKK0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.45%ETHUSD+0.16%USDTUSD+0.01%XRPUSD+0.40%SOLUSD+1.37%TRXUSDT+1.06%ZECUSDT+19.23%DOGEUSD+0.52%XMRUSDT-2.55%LINKUSD+0.23%XLMUSD+2.49%BCHUSDT+0.59%UNIUSD+1.27%LTCUSD+0.01%TONUSD+29.54%HBARUSDT-1.63%SUIUSD+2.57%TAOUSDT+0.62%AAVEUSD-2.80%DOTUSDT+6.35%ICPUSDT+1.32%ONDOUSDT+3.17%WLDUSDT+1.83%ARBUSDT+7.84%ATOMUSDT-1.15%JUPUSDT-0.26%INJUSDT-0.98%STXUSDT+1.15%FETUSDT+2.57%PYTHUSDT-1.03%TIAUSDT+2.55%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+2.12%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+0.56%IOTAUSDT-0.05%AXSUSDT+0.14%FARTCOINUSDT-0.57%EOSUSDT-0.64%DYDXUSDT+0.21%ORDIUSDT+2.66%GALAUSDT-2.76%NOTUSDT+2.56%RONINUSDT-2.40%NVDA+0.37%AAPL+0.09%GOOGL-0.61%MSFT+0.25%AMZN+0.13%TSM+0.96%SPCX+5.15%META+0.17%AVGO+0.07%TSLA+0.09%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.43%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%ORCL+2.00%BAC-2.72%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%3988.HK+0.34%GE+1.91%1816.HK-0.69%MS-1.83%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.72%NZDUSD-1.71%EURUSD-1.17%AUDUSD-1.14%USDCHF+1.12%GBPUSD-1.04%USDTHB+0.98%CADJPY+0.89%NZDCAD-0.87%USDCAD+0.85%CHFJPY+0.72%GBPNZD+0.67%GBPJPY+0.65%NZDCHF-0.60%AUDJPY+0.57%EURNZD+0.55%AUDNZD+0.55%EURJPY+0.52%GBPTRY+0.41%EURCAD-0.36%GBPHKD+0.32%USDTRY+0.30%AUDCAD-0.30%GBPMXN-0.28%CADCHF+0.27%GBPCAD-0.20%USDILS+0.16%GBPAUD+0.11%EURGBP-0.08%USDCNH+0.06%GBPCHF+0.04%USDCOP-0.04%EURCHF-0.03%AUDCHF-0.03%USDHKD+0.02%NZDJPY+0.02%EURAUD0.00%SGDJPY0.00%CHFSGD0.00%NOKJPY0.00%EURCZK0.00%NZDSGD0.00%EURNOK0.00%NZDMXN0.00%PLNJPY0.00%USDMXN0.00%USDNOK0.00%EURPLN0.00%USDZAR0.00%CHFNOK0.00%USDPLN0.00%USDDKK0.00%USDSEK0.00%EURSEK0.00%GBPZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%GBPSGD0.00%USDSGD0.00%AUDSGD0.00%EURDKK0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.45%ETHUSD+0.16%USDTUSD+0.01%XRPUSD+0.40%SOLUSD+1.37%TRXUSDT+1.06%ZECUSDT+19.23%DOGEUSD+0.52%XMRUSDT-2.55%LINKUSD+0.23%XLMUSD+2.49%BCHUSDT+0.59%UNIUSD+1.27%LTCUSD+0.01%TONUSD+29.54%HBARUSDT-1.63%SUIUSD+2.57%TAOUSDT+0.62%AAVEUSD-2.80%DOTUSDT+6.35%ICPUSDT+1.32%ONDOUSDT+3.17%WLDUSDT+1.83%ARBUSDT+7.84%ATOMUSDT-1.15%JUPUSDT-0.26%INJUSDT-0.98%STXUSDT+1.15%FETUSDT+2.57%PYTHUSDT-1.03%TIAUSDT+2.55%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+2.12%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+0.56%IOTAUSDT-0.05%AXSUSDT+0.14%FARTCOINUSDT-0.57%EOSUSDT-0.64%DYDXUSDT+0.21%ORDIUSDT+2.66%GALAUSDT-2.76%NOTUSDT+2.56%RONINUSDT-2.40%
MT

Maze Therapeutics, Inc. (MAZE)

NASDAQ • Healthcare

$23.91
-$0.31 (-1.3%)
Market closed

Last close at September 16, 2026 at 20:00 UTC

Open$24.33
Day Range$23.74 - $24.72
Avg. Volume (3M)463K
Market Cap$1.3B
52 Week Range
$22.45$53.65
Next EarningsIn 50 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$20M
Net Income (TTM)
-$133.5M
EPS (TTM)
-$2.74
ROA (TTM)
-25.13%
Current Ratio
18.31

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+11.0%Q1 2026-$0.65
-4.7%Q2 2026-$0.45
-6.0%Q3 2026-$0.76
Next

Nov 5

in 50 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -6.0%

Maze Therapeutics’ loss per share trailed consensus in the second fiscal quarter of 2026, based on preliminary results reported August 12, 2026, with EPS of -$0.76 trailing the -$0.72 estimate (difference -$0.04) as the early-stage biotech continued investing in its genetic-medicine pipeline across kidney and metabolic disease programs. The company posted GAAP net income of roughly -$44.7 million, a -32.8% year-over-year change from about -$33.7 million a year ago, alongside GAAP operating income of around -$48.0 million. Cash use also remained elevated, with negative operating cash flow of about -$15.1 million during the quarter. For the next period, consensus calls for EPS of -$0.79 on revenue of $333,333.00.

View full earnings history

About Maze Therapeutics, Inc.

Maze Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing genetic-medicine candidates in the United States. In qualitative terms it is an early-stage drug developer rather than a commercial biopharma company. The pipeline centers on kidney and metabolic diseases, and the company came public in 2025.

Name
Maze Therapeutics, Inc.
CEO
Jason Coloma
Website
www.mazetx.com
Industry
Healthcare
Year Founded
2017
Employees
141

Today's Snapshot

AI-generated

MAZE closed 1.3% below yesterday's close, while its sector was flat. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (559.7K)

385.6K

vs S&P 500 Today

Underperforming Market

-0.72%

Updated: September 16, 2026 at 20:19 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
MAZE exhibits a broadly bearish technical picture with consistent selling pressure across moving averages and momentum indicators despite deeply oversold oscillators. The MACD is negative and short-term momentum readings are weak while the price sits well below the 10/20/50 and 200-period averages, reflecting a dominant downtrend. Volume-based OBV is negative and volatility is elevated as shown by a sizable ATR, which underscores downside conviction. Stochastics and Williams %R read as oversold, suggesting short-term exhaustion but not reversing the broader bias. Technical takeaway: Strong Sell — pervasive bearish averages, negative momentum and weak volume dominate despite oversold signals.
All signals
  • EMA (5 indicators)$25.19 - $31.59
    Sell
  • RSI (14)31.30
    Neutral
  • Stochastic %K (14, 3, 3)6.15
    Buy
  • MACD Level (12, 26)-1.07
    Sell

Peers & Related Assets

SYRESpyre Therapeutics, Inc.
$91.17+0.2%
IMNMImmunome, Inc.
$23.46-2.0%
BCRXBioCryst Pharmaceuticals, Inc.
$8.43+3.3%
TRVITrevi Therapeutics, Inc.
$15.01-0.2%
ZYMEZymeworks Inc.
$26.24+0.7%
NTLAIntellia Therapeutics, Inc.
$11.49+1.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.